Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells

Journal of Immunology

Volumn 182, Issue 5, 2009, Pages 2909-2918

  Salek Ardakani, Shahram ^a   Arens, Ramon ^a   Flynn, Rachel ^a   Sette, Alessandro ^a   Schoenberger, Stephen P ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD8ALPHA ANTIGEN; GREEN FLUORESCENT PROTEIN; VACCINIA VACCINE; CD8 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; CD86 PROTEIN, MOUSE; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VACCINIA VIRUS; VIRUS INFECTION; ACUTE DISEASE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VACCINIA; VIROLOGY;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD8; ANTIGENS, CD80; ANTIGENS, CD86; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; VACCINIA; VACCINIA VIRUS;

EID: 64849094033     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803545     Document Type: Article

References (61)

1. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
2. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
3. Alegre, M. L., K. A. Frauwirth, and C. B. Thompson. 2001. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1: 220-228.
4. Salek-Ardakani, S., and M. Croft. 2006. Regulation of CD4 T cell memory by OX40 (CD134). Vaccine 24: 872-883.
5. Christensen, J. E., J. P. Christensen, N. N. Kristensen, N. J. Hansen, A. Stryhn, and A. R. Thomsen. 2002. Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells. Int. Immunol. 14: 701-711.
6. + effector T cell responses. J. Immunol. 164: 3689-3697.
7. Edelmann, K. H., and C. B. Wilson. 2001. Role of CD28/CD80-86 and CD40/ CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J. Virol. 75: 612-621.
8. Bertram, E. M., A. Tafuri, A. Shahinian, V. S. Chan, L. Hunziker, M. Recher, P. S. Ohashi, T. W. Mak, and T. H. Watts. 2002. Role of ICOS versus CD28 in antiviral immunity. Eur. J. Immunol. 32: 3376-3385.
9. + T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J. Immunol. 164: 1216-1222.
10. + T cell activation. Int. Immunol. 10: 619-630.
11. Motta, I., Y. C. Lone, and P. Kourilsky. 1998. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density. Eur. J. Immunol. 28: 3685-3695.
12. + T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions. J. Immunol. 160: 3180-3187.
13. Sepulveda, H., A. Cerwenka, T. Morgan, and R. W. Dutton. 1999. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 163: 1133-1142.
14. Wen, T., K. Kono, A. Shahinian, R. Kiessling, T. W. Mak, and G. Klein. 1997. CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors. Eur. J. Immunol. 27: 1988-1993.
15. Kawai, K., A. Shahinian, T. W. Mak, and P. S. Ohashi. 1996. Skin allograft rejection in CD28-deficient mice. Transplantation 61: 352-355.
16. + T cells in vitro. J. Exp. Med. 183: 2247-2257.
17. + T cell effectors: amplification of the lytic potential by B7. J. Immunol. 163: 2999-3006.
18. + T cells in vitro. J. Immunol. 163: 1298-1305.
19. Guerder, S., S. R. Carding, and R. A. Flavell. 1995. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. J. Immunol. 155: 5167-5174.
20. McAdam, A. J., B. E. Gewurz, E. A. Farkash, and A. H. Sharpe. 2000. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL. J. Immunol. 165: 3088-3093.
21. Suresh, M., J. K. Whitmire, L. E. Harrington, C. P. Larsen, T. C. Pearson, J. D. Altman, and R. Ahmed. 2001. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J. Immunol. 167: 5565-5573.
22. Bachmann, M. F., K. McKall-Faienza, R. Schmits, D. Bouchard, J. Beach, D. E. Speiser, T. W. Mak, and P. S. Ohashi. 1997. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7: 549-557.
23. Kundig, T. M., A. Shahinian, K. Kawai, H. W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5: 41-52.
24. Liu, Y., R. H. Wenger, M. Zhao, and P. J. Nielsen. 1997. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185: 251-262.
25. Hendriks, J., Y. Xiao, and J. Borst. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198: 1369-1380.
26. Lyon, A. B., and S. R. Sarawar. 2006. Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68. Virology 356: 50-56.
27. + T-cell function and immune surveillance of murine gammaherpesvirus 68. J. Virol. 80: 9159-9170.
28. -/- mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68. J. Virol. 76: 3049-3053.
29. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
30. Sansom, D. M., C. N. Manzotti, and Y. Zheng. 2003. What's the difference between CD80 and CD86? Trends Immunol. 24: 314-319.
31. Amanna, I. J., M. K. Slifka, and S. Crotty. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211: 320-337.
32. Harrington, L. E., R. Most Rv, J. L. Whitton, and R. Ahmed. 2002. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76: 3329-3337.
33. Xu, R., A. J. Johnson, D. Liggitt, and M. J. Bevan. 2004. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172: 6265-6271.
34. CD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24: 817-819.
35. + T cell-mediated resistance to an acute viral disease in a natural host. J. Immunol. 177: 8027-8036.
36. + T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J. Immunol. 180: 1148-1157.
37. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201: 95-104.
38. Davies, D. H., M. M. McCausland, C. Valdez, D. Huynh, J. E. Hernandez, Y. Mu, S. Hirst, L. Villarreal, P. L. Felgner, and S. Crotty. 2005. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 79: 11724-11733.
39. Salek-Ardakani, S., T. So, B. S. Halteman, A. Altman, and M. Croft. 2004. Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase Cθ. J. Immunol. 173: 6440-447.
40. + endritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172: 1996-000.
41. Matulonis, U., C. Dosiou, G. Freeman, C. Lamont, P. Mauch, L. M. Nadler, and J. D. Griffin. 1996. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity: further evidence that B7-1 and B7-2 are functionally distinct. J. Immunol. 156: 1126-131.
42. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156: 465-72.
43. Gajewski, T. F., F. Fallarino, C. Uyttenhove, and T. Boon. 1996. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol. 156: 2909-917.
44. + TCR-transgenic T cells. J. Immunol. 161: 5268-5275.
45. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154: 97-105.
46. Natesan, M., Z. Razi-Wolf, and H. Reiser. 1996. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J. Immunol. 156: 2783-2791.
47. Mark, D. A., C. E. Donovan, G. T. De Sanctis, H. Z. He, M. Cernadas, L. Kobzik, D. L. Perkins, A. Sharpe, and P. W. Finn. 2000. B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 22: 265-271.
48. Harris, N. L., M. Prout, R. J. Peach, B. Fazekas de St Groth, and F. Ronchese. 2001. CD80 costimulation is required for Th2 cell cytokine production but not for antigen-specific accumulation and migration into the lung. J. Immunol. 166: 4908-4914.
49. Greenwald, R. J., P. Lu, M. J. Halvorson, X. Zhou, S. Chen, K. B. Madden, P. J. Perrin, S. C. Morris, F. D. Finkelman, R. Peach, et al. 1997. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 158: 4088-4096.
50. Greenwald, R. J., J. F. Urban, M. J. Ekkens, S. Chen, D. Nguyen, H. Fang, F. D. Finkelman, A. H. Sharpe, and W. C. Gause. 1999. B7-2 is required for the progression but not the initiation of the type 2 immune response to a gastrointestinal nematode parasite. J. Immunol. 162: 4133-4139.
51. + cytotoxic Tlymphocyte generation in the host response to vesicular stomatitis virus. J. Virol. 74: 203-208.
52. Sigal, L. J., H. Reiser, and K. L. Rock. 1998. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J. Immunol. 161: 2740-2745.
53. Servet-Delprat, C., P. O. Vidalain, H. Bausinger, S. Manie, F. Le Deist, O. Azocar, D. Hanau, A. Fischer, and C. Rabourdin-Combe. 2000. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J. Immunol. 164: 1753-1760.
54. Coscoy, L., and D. Ganem. 2001. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107: 1599-1606.
55. Salek-Ardakani, S., J. R. Arrand, and M. Mackett. 2002. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 304: 342-351.
56. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745.
57. Morrow, G., B. Slobedman, A. L. Cunningham, and A. Abendroth. 2003. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol. 77: 4950-4959.
58. Mintern, J. D., E. J. Klemm, M. Wagner, M. E. Paquet, M. D. Napier, Y. M. Kim, U. H. Koszinowski, and H. L. Ploegh. 2006. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus Fc receptor-1. J. Immunol. 177: 8422-8431.
59. Loewendorf, A., C. Kruger, E. M. Borst, M. Wagner, U. Just, and M. Messerle. 2004. Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol. 78: 13062-13071.
60. Chaudhry, A., S. R. Das, A. Hussain, S. Mayor, A. George, V. Bal, S. Jameel, and S. Rath. 2005. The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J. Immunol. 175: 4566-4574.
61. Majumder, B., M. L. Janket, E. A. Schafer, K. Schaubert, X. L. Huang, J. Kan-Mitchell, C. R. Rinaldo, Jr., and V. Ayyavoo. 2005. Human immunode-ficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J. Virol. 79: 7990-8003.